TAKEDA PHARMACEUTIC-SP ADR (TAK) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:TAK • US8740602052
17.23 USD
+0.06 (+0.35%)
At close: Jan 30, 2026
17.24 USD
+0.01 (+0.06%)
After Hours: 1/30/2026, 8:20:30 PM
TAK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. While TAK belongs to the best of the industry regarding profitability, there are concerns on its financial health. TAK has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- TAK had positive earnings in the past year.
- TAK had a positive operating cash flow in the past year.
- In the past 5 years TAK has always been profitable.
- Each year in the past 5 years TAK had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of TAK (0.23%) is better than 78.01% of its industry peers.
- TAK's Return On Equity of 0.46% is fine compared to the rest of the industry. TAK outperforms 79.58% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 1.87%, TAK is in the better half of the industry, outperforming 79.06% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for TAK is significantly below the industry average of 12.82%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.23% | ||
| ROE | 0.46% | ||
| ROIC | 1.87% |
ROA(3y)1.33%
ROA(5y)1.73%
ROE(3y)2.84%
ROE(5y)3.97%
ROIC(3y)2.62%
ROIC(5y)2.55%
1.3 Margins
- Looking at the Profit Margin, with a value of 0.75%, TAK is in the better half of the industry, outperforming 78.01% of the companies in the same industry.
- TAK's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 8.46%, TAK belongs to the top of the industry, outperforming 80.10% of the companies in the same industry.
- TAK's Operating Margin has improved in the last couple of years.
- TAK has a Gross Margin of 64.60%. This is in the better half of the industry: TAK outperforms 74.35% of its industry peers.
- TAK's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.46% | ||
| PM (TTM) | 0.75% | ||
| GM | 64.6% |
OM growth 3Y-8.47%
OM growth 5Y6.13%
PM growth 3Y-28.5%
PM growth 5Y11.87%
GM growth 3Y-1.71%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TAK is still creating some value.
- The number of shares outstanding for TAK has been increased compared to 1 year ago.
- The number of shares outstanding for TAK has been increased compared to 5 years ago.
- The debt/assets ratio for TAK has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.25, we must say that TAK is in the distress zone and has some risk of bankruptcy.
- TAK has a Altman-Z score of 1.25. This is comparable to the rest of the industry: TAK outperforms 56.02% of its industry peers.
- The Debt to FCF ratio of TAK is 5.04, which is a neutral value as it means it would take TAK, 5.04 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 5.04, TAK belongs to the best of the industry, outperforming 83.25% of the companies in the same industry.
- TAK has a Debt/Equity ratio of 0.61. This is a neutral value indicating TAK is somewhat dependend on debt financing.
- TAK has a Debt to Equity ratio of 0.61. This is in the lower half of the industry: TAK underperforms 68.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.04 | ||
| Altman-Z | 1.25 |
ROIC/WACC1.15
WACC1.63%
2.3 Liquidity
- A Current Ratio of 1.36 indicates that TAK should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.36, TAK is not doing good in the industry: 73.82% of the companies in the same industry are doing better.
- A Quick Ratio of 0.76 indicates that TAK may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.76, TAK is doing worse than 84.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.76 |
3. Growth
3.1 Past
- TAK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.38%.
- Measured over the past years, TAK shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.20% on average per year.
- Looking at the last year, TAK shows a decrease in Revenue. The Revenue has decreased by -2.84% in the last year.
- Measured over the past years, TAK shows a small growth in Revenue. The Revenue has been growing by 6.84% on average per year.
EPS 1Y (TTM)-88.38%
EPS 3Y-22.57%
EPS 5Y19.2%
EPS Q2Q%-112.87%
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y8.68%
Revenue growth 5Y6.84%
Sales Q2Q%-5.38%
3.2 Future
- TAK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.21% yearly.
- TAK is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.03% yearly.
EPS Next Y74.27%
EPS Next 2Y67.89%
EPS Next 3Y45.21%
EPS Next 5YN/A
Revenue Next Year-1.77%
Revenue Next 2Y-0.66%
Revenue Next 3Y-0.03%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 246.14, TAK can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of TAK indicates a somewhat cheap valuation: TAK is cheaper than 75.39% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.32, TAK is valued quite expensively.
- Based on the Price/Forward Earnings ratio of 27.58, the valuation of TAK can be described as expensive.
- Based on the Price/Forward Earnings ratio, TAK is valued a bit cheaper than 73.30% of the companies in the same industry.
- TAK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 246.14 | ||
| Fwd PE | 27.58 |
4.2 Price Multiples
- 87.96% of the companies in the same industry are more expensive than TAK, based on the Enterprise Value to EBITDA ratio.
- 92.15% of the companies in the same industry are more expensive than TAK, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.09 | ||
| EV/EBITDA | 10.95 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TAK does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of TAK may justify a higher PE ratio.
- TAK's earnings are expected to grow with 45.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.31
PEG (5Y)12.82
EPS Next 2Y67.89%
EPS Next 3Y45.21%
5. Dividend
5.1 Amount
- TAK has a Yearly Dividend Yield of 3.88%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.62, TAK pays a better dividend. On top of this TAK pays more dividend than 96.34% of the companies listed in the same industry.
- TAK's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.88% |
5.2 History
- The dividend of TAK has a limited annual growth rate of 1.18%.
- TAK has paid a dividend for at least 10 years, which is a reliable track record.
- TAK has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.18%
Div Incr Years2
Div Non Decr Years3
5.3 Sustainability
- TAK pays out 935.06% of its income as dividend. This is not a sustainable payout ratio.
- TAK's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP935.06%
EPS Next 2Y67.89%
EPS Next 3Y45.21%
TAKEDA PHARMACEUTIC-SP ADR / TAK FAQ
What is the fundamental rating for TAK stock?
ChartMill assigns a fundamental rating of 5 / 10 to TAK.
What is the valuation status for TAK stock?
ChartMill assigns a valuation rating of 5 / 10 to TAKEDA PHARMACEUTIC-SP ADR (TAK). This can be considered as Fairly Valued.
What is the profitability of TAK stock?
TAKEDA PHARMACEUTIC-SP ADR (TAK) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for TAK stock?
The Price/Earnings (PE) ratio for TAKEDA PHARMACEUTIC-SP ADR (TAK) is 246.14 and the Price/Book (PB) ratio is 1.18.
How financially healthy is TAKEDA PHARMACEUTIC-SP ADR?
The financial health rating of TAKEDA PHARMACEUTIC-SP ADR (TAK) is 3 / 10.